HZNP Limited, also known as Horizon Therapeutics, is a biopharmaceutical company headquartered in Ireland (IE). Founded in 2008, HZNP has established itself as a leader in the development of innovative therapies for rare and autoimmune diseases, with a strong operational presence in North America and Europe. The company is renowned for its core products, including Tepezza and Krystexxa, which address significant unmet medical needs. HZNP's commitment to research and development has led to notable achievements, positioning it as a key player in the biopharmaceutical industry. With a focus on patient-centric solutions, HZNP Limited continues to drive advancements that improve the quality of life for individuals affected by complex health conditions.
We don't have data for HZNP Limited, but we can show you information about their parent organization instead.
View parent company